Product Name | MF | CAS | Details |
---|
HIV-1 protease-IN-8 | C25H35N3O5S | 2925287-55-2 | Details |
Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
ATR-IN-23 | C20H22N6O3S2 | 2923800-62-6 | Details |
TNF-α-IN-10 | C17H14O4 | 2247720-56-3 | Details |
Lp-PLA2-IN-12 | 2637485-14-2 | Details |
Antileishmanial agent-16 | C27H37N5O4 | 2934738-41-5 | Details |
Antileishmanial agent-15 | C28H39N5O4 | 2934738-38-0 | Details |
HIV-1 inhibitor-56 | C22H14ClN7O2S | 2952530-45-7 | Details |
Antibacterial agent 141 | C23H27ClN2O3 | 2930013-56-0 | Details |
PB131 | C16H16FN3O2 | 2924425-63-6 | Details |
TRK-IN-23 | C20H17FN4O2 | 2924344-29-4 | Details |
Antileishmanial agent-17 | C27H37N5O5 | 2934738-40-4 | Details |
Bromodomain inhibitor-12 | 2010124-06-6 | Details |
TLR7/8 agonist 9 | C20H26N6O | 2649170-17-0 | Details |
PCSK9-IN-17 | C16H19N5OS | 2455424-72-1 | Details |
IRE1α kinase-IN-9 | C24H24N2O6 | 1338933-30-4 | Details |
Lp-PLA2-IN-13 | C22H17F5N4O4 | 2756855-62-4 | Details |
RIP1 kinase inhibitor 4 | 2919836-00-1 | Details |
Bromodomain inhibitor-12 (edisylate) | C28H38N4O5.C2H6O6S2 | 2010124-27-1 | Details |
Antifungal agent 59 | 2422019-96-1 | Details |
MEK-IN-6 hydrate | 2845153-35-5 | Details |
THRβ receptor agonist-1 | 2403721-00-4 | Details |
HPK1 antagonist-1 | C28H29FN6O2 | 2628489-56-3 | Details |
RIP1 kinase inhibitor 7 | C20H20FN3O | 2428401-23-2 | Details |
MEK-IN-6 | C18H20FN3O4S | 2845151-86-0 | Details |
IRE1α kinase-IN-8 | 1338933-29-1 | Details |
Mcl-1 inhibitor 13 | 2445466-06-6 | Details |
Lp-PLA2-IN-14 | 2756855-66-8 | Details |
ROCK-IN-6 | C19H19N5O8S | 2489328-74-5 | Details |
SHP2-IN-14 | C22H20Cl2N8O | 2673400-91-2 | Details |
P2X3 antagonist 38 | C22H25F3N6O3 | 2545974-71-6 | Details |
Mosnodenvir | C26H22ClF3N2O6S | 2890688-86-3 | Details |
KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
JAK-IN-28 | C20H18ClN7O | 2445500-22-9 | Details |
SOS1/KRAS-IN-1 | C24H26F3N5O | 2836330-34-6 | Details |
PI3Kγ inhibitor 7 | C31H25N9O2 | 2575863-25-9 | Details |
K-80001 | C20H17FO2 | 242800-40-4 | Details |
SOS1-IN-16 | C30H31F3N4O3 | 2930763-85-0 | Details |
Antiproliferative agent-30 | C24H26N4O4 | 2713553-88-7 | Details |
IRAK4-IN-28 | C27H31N9O3 | 2952532-92-0 | Details |
PAD4-IN-2 | C20H23BClN7O6 | 2642327-52-2 | Details |
S-Gem | C13H15F2N3O6S2 | 2169925-98-6 | Details |
UPCDC30766 | C30H32F2N6O3S | 2152623-68-0 | Details |
Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
DSO-5a | C23H24N2O7 | 2195411-63-1 | Details |
Antitumor agent-101 | C26H38N6O3 | 2848632-52-8 | Details |
FGFR-IN-11 | C28H29ClN4O4 | 2658488-68-5 | Details |
BDM91514 | 2892824-90-5 | Details |
Antiproliferative agent-34 | C27H27N7O5 | 2910858-34-1 | Details |
BBDDL2059 | C27H36N4O4S | 2691174-27-1 | Details |
SARS-CoV-2-IN-57 | C23H37N3O | 1265624-68-7 | Details |
Anticancer agent 147 | C32H40BrN3O2 | 2241283-11-2 | Details |
MmpL3-IN-2 | C27H30N2 | 2944458-65-3 | Details |
Tubulin polymerization-IN-42 | C22H21NO5 | 2640220-51-3 | Details |
BChE-IN-17 | C23H23BrN2O4S2 | 2425632-57-9 | Details |
Antiproliferative agent-32 | C19H15NO2 | 2925814-05-5 | Details |
ETAP | C18H17N3O | 2575731-47-2 | Details |
JAK-IN-30 | C19H26N8S | 2891469-99-9 | Details |
AMPK activator 11 | C25H20N4O2 | 2948304-00-3 | Details |
SUCNR1-IN-1 | C26H22ClF3N2O4 | 2711753-52-3 | Details |
FKBP51F67V-selective antagonist Ligand2 | C43H56N2O10 | 1680228-76-5 | Details |
STAT6-IN-3 | C32H35IN3O7P | 371919-80-1 | Details |
URAT1&XO inhibitor 1 | C20H13N5O3S | 2669726-78-5 | Details |
CDK7-IN-22 | C22H25F3N6 | 2173190-60-6 | Details |
URAT1&XO inhibitor 2 | C14H12BrNO3 | 1239488-96-0 | Details |
PROTAC α-synuclein degrader 5 | C39H41N7O10 | 2781922-42-5 | Details |
PHD2-IN-1 | C21H23ClN4O5 | 2768219-28-7 | Details |
PIKfyve-IN-2 | C22H22N8O | 2245319-25-7 | Details |
MAT2A-IN-12 | C20H17NO3 | 631897-75-1 | Details |
SSI-4 | C19H21ClN4O3 | 1875084-68-6 | Details |
DRI-C25441 | C31H21N3O6 | 2101765-83-5 | Details |
Protein kinase inhibitor 5 | C29H31F2N7O | 2278204-94-5 | Details |
TLR8 agonist 6 | C19H29N7O2 | 2616605-55-9 | Details |
IPG7236 | C23H31N3O3S | 2756350-91-9 | Details |
RET-IN-23 | C28H28FN11 | 2479961-46-9 | Details |
SORT-PGRN interaction inhibitor 3 | C15H19Cl2NO3 | 2691846-87-2 | Details |
Lp-PLA2-IN-16 | C22H17F5N4O3 | 1865780-73-9 | Details |
PCSK9-IN-16 | C16H20N6O2S3 | 2455424-51-6 | Details |
Tau protein aggregation-IN-1 | C17H11BrN2O2 | 916179-45-8 | Details |
VMAT2-IN-2 tosylate | C27H36F3NO6S | 2608770-12-1 | Details |
RIP1 kinase inhibitor 5 | C13H17F2NO2 | 2428422-17-5 | Details |
RIP1 kinase inhibitor 6 | C19H18F2N2O3 | 2428401-62-9 | Details |
Enpp-1-IN-17 | C18H24N4O2 | 2289736-54-3 | Details |
Tegeprotafib | C13H11FN2O5S | 2407610-46-0 | Details |
CXCR4-IN-1 | C23H32N6 | 2304750-48-7 | Details |
HDAC ligand-1 | C7H8N2O | 34840-28-3 | Details |
ALK2-IN-5 | C24H32N8O2 | 2414149-20-3 | Details |
Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
SLMP53-2 | C26H22N2O2 | 1826116-38-4 | Details |
MDM2/XIAP-IN-2 | C29H32N2O4S | 2761969-85-9 | Details |
AMPA receptor modulator-4 | C11H12ClFN2O2S | 2917551-59-6 | Details |
DRI-C21041 | C30H21N3O7S | 2101765-78-8 | Details |
DGKζ-IN-1 | C27H25F3N6O2S | 2660218-70-0 | Details |
A1/A3 AR antagonist 3 | C22H19N5O3 | 2665804-57-7 | Details |
Bivamelagon hydrochloride | C35H54Cl2N4O4 | 2641595-55-1 | Details |
Bivamelagon | C35H53ClN4O4 | 2641595-54-0 | Details |
TLR7/8 agonist 8 | C24H30N6O | 2649170-16-9 | Details |
ATR-IN-24 | C23H26N6O2 | 2370889-43-1 | Details |
Lp-PLA2-IN-15 | C22H17F5N4O3 | 1865796-11-7 | Details |
Product Total: Product Page: | ||||
24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 |